首页 | 本学科首页   官方微博 | 高级检索  
检索        


Comparative effect of saxagliptin and glimepiride with a composite endpoint of adequate glycaemic control without hypoglycaemia and without weight gain in patients uncontrolled with metformin therapy: Results from the SPECIFY study,a 48-week,multi-centre,randomized, controlled trial
Authors:Tianwei Gu MD  Jianhua Ma MD  Qiu Zhang MD  Liangying Zhu MD  Hong Zhang MD  Lan Xu MD  Jinluo Cheng MD  Bimin Shi MD  Dongmei Li MD  Jiaqing Shao MD  Zilin Sun MD  Shao Zhong MD  Yan Bi MD  Dalong Zhu MD
Institution:1. Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China;2. Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China;3. Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, China;4. Department of Endocrinology, Huai'an First People's Hospital, Huai'an, China;5. Department of Endocrinology, Wuxi First People's Hospital, Wuxi, China;6. Department of Endocrinology, Changzhou Second People's Hospital affiliated to Nanjing Medical University, Changzhou, China;7. Department of Endocrinology, The First Affiliated Hospital of Soochow University, Suzhou, China;8. Department of Endocrinology, Nanjing Pukou District Central Hospital, Nanjing, China;9. Department of Endocrinology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China;10. Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, China;11. Department of Endocrinology, Kunshan First People's Hospital, Suzhou, China
Abstract:
Keywords:DPP-IV inhibitor  randomized trial  sulfonylurea  type 2 diabetes
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号